Tadalafil Tablets
Tadalafil is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each individual product listing.
PDE5 Inhibitor
Browse Tadalafil products for erectile dysfunction and compare labeled tablet strengths, package quantities, manufacturers, published lab reports and current USA Domestic or International Warehouse availability.
Trade Name: Cialis
Compound: Tadalafil Citrate
Strength: 50 mg/pill
Container: 100 Pills
Manufacturer: Stealth Labs USA
Lab Tested: View Result
Shipped Without Label!
PDE5 Inhibitor
The Tadalafil category brings together available products containing this phosphodiesterase type 5 (PDE5) inhibitor, widely associated with the Cialis brand name. Tadalafil is used medically for erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia. Browse available products and compare labeled tablet strengths, package quantities, manufacturers, published laboratory testing, pricing and USA Domestic or International warehouse availability.
Tadalafil is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each individual product listing.
Tadalafil has a longer duration of pharmacological activity than several other commonly used PDE5 inhibitors, which is one of its distinguishing characteristics.
Where laboratory reports are available, individual product pages provide access to measured results, testing dates and reported batch information.
Tadalafil products may be stocked in the USA Domestic Warehouse, International Warehouse or both depending on current inventory.
Tadalafil is a prescription medicine belonging to the phosphodiesterase type 5 (PDE5) inhibitor class. In the United States, Tadalafil products are indicated for erectile dysfunction, the signs and symptoms of benign prostatic hyperplasia (BPH), and combined ED/BPH in appropriate patients.
Tadalafil is not Testosterone, an anabolic-androgenic steroid or a hormone-replacement medicine. Its effects involve PDE5 inhibition and vascular smooth-muscle signaling rather than supplying an androgen.
Tadalafil identifies the active pharmaceutical ingredient, while Cialis is the best-known brand name associated with Tadalafil for erectile dysfunction and BPH.
Generic and manufacturer-specific products can use different branding and packaging while containing the same active substance. When comparing products, check the active ingredient, labeled tablet strength, package quantity and manufacturer rather than relying solely on the brand name.
During sexual stimulation, nitric oxide signaling contributes to the formation of cyclic guanosine monophosphate (cGMP), which promotes smooth-muscle relaxation and increased blood flow within erectile tissue.
PDE5 normally breaks down cGMP. Tadalafil inhibits PDE5 and allows this signaling to persist longer, supporting the normal erectile response when sexual stimulation occurs.
This means Tadalafil does not simply produce an erection independently of sexual stimulation and should not be confused with a medicine that directly increases sexual desire.
Tadalafil has an established medical role in the treatment of erectile dysfunction (ED). ED refers to persistent difficulty achieving or maintaining an erection sufficient for sexual activity.
Erectile dysfunction can have many underlying causes, including cardiovascular disease, diabetes, neurological conditions, medications, psychological factors and hormonal disorders.
A PDE5 inhibitor can improve erectile function without necessarily correcting the underlying cause. Persistent or newly developing ED can therefore warrant appropriate medical evaluation.
One of Tadalafil's best-known characteristics is its long elimination half-life, which is approximately 17.5 hours. This contributes to a longer period of pharmacological activity compared with several other PDE5 inhibitors.
A longer duration does not mean that an erection remains continuously present. PDE5 inhibitors support erectile response when sexual stimulation occurs rather than producing uninterrupted erectile activity.
The longer pharmacokinetic profile is also one reason Tadalafil has both as-needed and once-daily treatment approaches within its approved clinical uses.
Tadalafil is also indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). BPH is a noncancerous enlargement of the prostate that can contribute to urinary symptoms such as hesitancy, weak stream, urgency and incomplete emptying.
This additional indication distinguishes Tadalafil from some other erectile-dysfunction medicines that are primarily associated with ED.
BPH symptoms can overlap with other urinary or prostate conditions, so persistent urinary symptoms should be appropriately evaluated rather than assumed to represent benign enlargement.
Tadalafil and Sildenafil are both PDE5 inhibitors used for erectile dysfunction, but they have notably different pharmacokinetic characteristics.
Tadalafil has a substantially longer half-life and duration of action, while Sildenafil generally has a shorter active window and different timing characteristics.
Sildenafil is widely associated with Viagra, while Tadalafil is associated with Cialis. Neither difference means that one medicine is universally preferable; individual suitability depends on health history, other medicines and desired treatment characteristics.
Tadalafil and Avanafil belong to the same PDE5 inhibitor class but emphasize different pharmacokinetic characteristics.
Avanafil is commonly differentiated by its relatively rapid onset, while Tadalafil is especially recognized for its longer duration of pharmacological activity.
Their labeled strengths, timing characteristics, interactions and individual tolerability differ, so the two should be compared as distinct medicines rather than interchangeable products.
Tadalafil and Vardenafil both inhibit PDE5 and are used in erectile-dysfunction treatment, but they have distinct pharmacokinetic and product characteristics.
Tadalafil's extended duration is one of the most obvious differences. Vardenafil generally has a shorter pharmacological window and its own interaction and safety considerations.
When comparing PDE5 inhibitors, start with the actual active ingredient rather than assuming similar indications mean identical products.
When browsing Tadalafil products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.
Products containing Tadalafil can differ in tablet strength, package quantity and manufacturer-specific presentation. Reviewing the complete product specification provides a clearer comparison than relying on branding or price alone.
The labeled mg-per-tablet strength identifies the amount of Tadalafil stated in each tablet. Package quantity separately identifies the total number of tablets supplied.
Two Tadalafil products can therefore contain the same active ingredient while differing in tablet strength or package quantity. Check both specifications when comparing available products.
Selected Tadalafil products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.
Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different batches or testing dates can be reviewed individually.
Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.
In addition to its use for ED and BPH, Tadalafil is also used in separate pharmaceutical products for pulmonary arterial hypertension (PAH).
These are different therapeutic contexts with different product labeling and treatment frameworks. A Tadalafil product intended for one indication should not automatically be treated as interchangeable with another product simply because the active ingredient is the same.
This is similar to Sildenafil, another PDE5 inhibitor that also has both erectile-dysfunction and pulmonary-hypertension contexts.
One of the most important safety considerations with Tadalafil is its interaction with organic nitrate medicines.
Combining Tadalafil with nitrates can produce an excessive and potentially dangerous reduction in blood pressure. Concomitant nitrate use is therefore contraindicated.
Tadalafil's long pharmacokinetic profile is particularly relevant here. Current prescribing information states that, when nitrate treatment becomes medically necessary after Tadalafil exposure, at least 48 hours should generally have elapsed after the last dose before nitrates are considered under appropriate medical supervision.
Tadalafil can interact with medicines that affect blood pressure or its metabolism. Alpha-blockers, antihypertensive medicines and potent CYP3A4 inhibitors can be relevant depending on the clinical circumstances.
Its longer persistence in the body also means interactions can remain relevant beyond the immediate time a tablet is taken.
Tadalafil should not simply be combined with another PDE5 inhibitor in an attempt to increase erectile response. A complete medication list provides far more useful safety information than tablet strength alone.
Both Tadalafil and substantial alcohol intake can influence blood pressure. Combining them can increase the likelihood of symptoms such as dizziness, headache, increased heart rate or orthostatic hypotension in some individuals.
The relevance depends on the amount of alcohol consumed, cardiovascular health and other medications. The absence of immediate symptoms should not be interpreted as meaning there is no interaction.
Tadalafil is a pharmacologically active prescription medicine. Common adverse effects can include headache, indigestion, flushing, nasal congestion, back pain and muscle aches.
Because sexual activity can increase cardiovascular workload, underlying cardiovascular health is relevant when erectile-dysfunction treatment is being considered.
Rare but serious adverse events can include prolonged erection, sudden changes in vision and sudden hearing changes. Symptoms of this type require prompt medical evaluation.
A published laboratory report can provide information about an analyzed product sample but does not establish that taking Tadalafil is medically appropriate or safe for an individual. This category is intended for product identification and comparison and does not provide individualized erectile-dysfunction, BPH or dosing guidance.
An erection that persists for an unusually long period can represent priapism, a medical emergency because prolonged impairment of normal blood flow can damage erectile tissue.
An erection lasting more than four hours requires prompt medical attention. A prolonged erection should not be interpreted as evidence that a Tadalafil product is especially effective or high quality.
Rare but serious visual and hearing-related events have been reported in association with PDE5 inhibitors. Sudden loss or major reduction of vision or hearing warrants immediate medical evaluation.
Underlying cardiovascular risk factors and pre-existing eye or hearing conditions can be relevant to individual risk.
Tadalafil supports the physiological erectile response when sexual stimulation occurs. It does not primarily increase sexual desire.
Low libido and erectile dysfunction can have different underlying causes. A PDE5 inhibitor may improve erectile function without correcting low desire related to hormones, medications, psychological factors or other conditions.
No. Tadalafil is not Testosterone and is not an anabolic-androgenic steroid.
Low Testosterone can contribute to sexual symptoms in some individuals, but Tadalafil works through PDE5 inhibition and vascular signaling rather than supplying or replacing testosterone.
This distinction is particularly useful within a catalog containing both hormonal products and sexual-health medicines.
Tadalafil does not protect against sexually transmitted infections and does not function as contraception.
Improving erectile function does not change the need for appropriate safer-sex practices or contraception where relevant.
Tadalafil products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.
For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.
Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.
Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Tadalafil products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.
Payment options and warehouse availability do not determine whether Tadalafil is medically appropriate for an individual. Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product.